Pfizer–BioNTech COVID-19 vaccine
Pfizer–BioNTech COVID-19 vaccine
Type of vaccine for humans.
No account needed. By playing, you confirm you're 13 or older and agree to the Terms of use.
No owners yet
Category: Empty
- 0 owners
- 0 copies
- 0 pulls
- Wishlisted
- 0
- In 0 albums
- On 0 showcases
- Market listings
- 0
Not sold on the market yet.
Readers' pathsAug 2026 – Oct 2026
Readers go next to
Share of the 4,669 clicks on its links
BioNTech
German biotechnology company.
21%
Pfizer
American multinational pharmaceutical and biotechnology corporation.
9.5%
MRNA vaccine
Type of vaccine.
8.3%
COVID-19 vaccine
Vaccine against SARS-CoV-2.
7.9%
Moderna COVID-19 vaccine
RNA COVID-19 vaccine.
6.2%
COVID-19 misinformation
False or misleading virus information.
4.4%
SARS-CoV-2
Virus that causes COVID-19.
4%
Injection (medicine)
Method of medication administration.
3.1%
Uğur Şahin
German oncologist and immunologist (born 1965).
2.9%
Myocarditis
Inflammation of the heart muscle.
2.9%
Readers come from
Share of the 5,516 readers arriving from another article
COVID-19 vaccine
Vaccine against SARS-CoV-2.
24%
Pfizer
American multinational pharmaceutical and biotechnology corporation.
10%
BioNTech
German biotechnology company.
9.6%
MRNA vaccine
Type of vaccine.
7.3%
Moderna COVID-19 vaccine
RNA COVID-19 vaccine.
5.1%
Albert Bourla
CEO of Pfizer (born 1961).
2.9%
COVID-19
Contagious disease caused by SARS-CoV-2.
2.3%
History of COVID-19 vaccine development
Scientific work to develop a vaccine for COVID-19.
2.1%
Uğur Şahin
German oncologist and immunologist (born 1965).
1.8%
Operation Warp Speed
US program to accelerate COVID-19 vaccine efforts.
1.7%